Interleukin‐6: A novel biomarker for monoclonal antibody and chemotherapy‐associated hypersensitivity confirms a cytokine release syndrome phenotype‐endotype association
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Endophenotyping Oxaliplatin Hypersensitivity: Personalizing Desensitization to the Atypical PlatinThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- Hypersensitivity reactions to therapeutic monoclonal antibodies: Phenotypes and endotypesJournal of Allergy and Clinical Immunology, 2018
- Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal AntibodiesThe Journal of Allergy and Clinical Immunology: In Practice, 2016
- IL-6 as a keystone cytokine in health and diseaseNature Immunology, 2015
- Rapid IgE desensitization is antigen specific and impairs early and late mast cell responses targeting FcεRI internalizationEuropean Journal of Immunology, 2011